Cost and cost‐effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV ‐positive pregnant and breastfeeding women in Swaziland-Reference-Cited by-同舟云学术

Cost and cost‐effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV ‐positive pregnant and breastfeeding women in Swaziland

Published:2018-07-26 Issue:9 Volume:23 Page:950-959
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Cunnama L.¹,Abrams E. J.²³,Myer L.⁴,Gachuhi A.²,Dlamini N.⁵,Hlophe T.⁶,Kikuvi J.⁷,Langwenya N.⁴,Mthethwa S.⁸,Mudonhi D.⁵,Nhlabatsi B.⁸,Nuwagaba‐Biribonwoha H.²⁵,Okello V.⁸,Sahabo R.²⁵,Zerbe A.²,Sinanovic E.¹

Affiliation:

1. Health Economics Unit School of Public Health & Family Medicine University of Cape Town Cape Town South Africa

2. Mailman School of Public Health ICAP at Columbia University New York NY USA

3. College of Physicians & Surgeons Columbia University New York NY USA

4. Division of Epidemiology & Biostatistics University of Cape Town Cape Town South Africa

5. ICAP at Columbia University Mbabane Swaziland

6. Monitoring & Evaluation Deputy Prime Minister's Office Mbabane Swaziland

7. Desmond Tutu HIV Foundation University of Cape Town Cape Town South Africa

8. Swaziland Ministry of Health Mbabane Swaziland

Funder

United States Agency for International Development

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tmi.13121

Reference33 articles.

1. Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda

2. World Health Organization(2015)Guideline on when to start antiretroviral therapy and on pre‐exposure prophylaxis for HIV. Geneva Switzerland. Available at:http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1.

3. World Health Organization(2012)Programmatic update: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva Switzerland. Available at:http://www.who.int/hiv/PMTCT_update.pdf.

4. HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions

5. Economic modeling of HIV treatments

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis;Frontiers in Public Health;2022-06-17

2. Health Economic Evaluation Alongside Stepped Wedge Trials: A Methodological Systematic Review;PharmacoEconomics;2020-10-05

3. Effects of in-hospital breast feeding on brain function development in preterm infants in China: study protocol for a prospective longitudinal cohort study;BMJ Open;2020-10

4. Cost variations in prevention of mother-to-child HIV transmission services integrated within maternal and child health services in rural Tanzania;Global Public Health;2020-07-29

5. Standardized framework for evaluating costs of active case-finding programs: An analysis of two programs in Cambodia and Tajikistan;PLOS ONE;2020-01-27